Regarding mRNA signatures, there were significant increases in the hepatic expression of YAP1, HSPD1, TNF, TEAD2, ITGB1, FOXA2, MMP14, and SMAD4, with significant decreases in LATS1, LATS2, AMOTL2, SOX11, and NF2 in both NASH groups, as against the Normal group. The gene discussed is LATS2; the disease is metabolic dysfunction-associated steatohepatitis.